Cargando…

Rapid reduction with cystic transformation of invasive giant prolactinoma following short term low dose cabergoline

Detalles Bibliográficos
Autores principales:	Dutta, Deep, Ghosh, Sujoy, Mukhopadhyay, Satinath, Chowdhury, Subhankar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2012
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3510941/ https://www.ncbi.nlm.nih.gov/pubmed/23226667 http://dx.doi.org/10.4103/2230-8210.103041

Ejemplares similares

Iatrogenic Cushing’s Syndrome Following Short-Term Intranasal Steroid Use
por: Dutta, Deep, et al.
Publicado: (2012)

Cabergoline Treatment in Invasive Giant Prolactinoma
por: Alsubaie, Sadeem, et al.
Publicado: (2014)

Percutaneous ethanol ablation in managing predominantly cystic thyroid nodules: An eastern India perspective
por: Basu, Nupur, et al.
Publicado: (2014)

Rathke's cyst with ectopic neurohypophysis presenting as severe short stature with delayed puberty
por: Dutta, Deep, et al.
Publicado: (2012)

Efficacy and safety of low dose oral prednisolone as compared to pulse intravenous methylprednisolone in managing moderate severe Graves’ orbitopathy: A randomized controlled trial
por: Roy, Ajitesh, et al.
Publicado: (2015)

Spontaneous reduction of prolactinoma post cabergoline withdrawal
por: Venkatesh, Sampath Kumar, et al.
Publicado: (2012)

Syndrome of Extreme Insulin Resistance (Rabson-Mendenhall Phenotype) with Atrial Septal Defect: Clinical Presentation and Treatment Outcomes
por: Dutta, Deep, et al.
Publicado: (2013)

Adrenal myelolipoma with keratoconus: A novel clinical association
por: Dutta, Deep, et al.
Publicado: (2012)

Growth hormone deficiency, secondary hypothyroidism, and empty sella following treatment of childhood macroprolactinoma
por: Selvan, Chitra, et al.
Publicado: (2013)

Panhypopituitarism with empty sella a sequel of pituitary hyperplasia due to chronic primary hypothyroidism
por: Dutta, Deep, et al.
Publicado: (2012)

Idiopathic hypoparathyroidism and systemic sclerosis: An association likely missed
por: Dutta, Deep, et al.
Publicado: (2012)

Beat the giant: case of a giant prolactinoma during pregnancy on cabergoline
por: Almistehi, Wael M, et al.
Publicado: (2018)

Abstract 94: Efficacy of cabergoline treatment in men with giant prolactinomas
Publicado: (2022)

Tetany due to hypoparathyroidism as the initial manifestation of autoimmune polyendocrine syndrome type-2: A case report
por: Dutta, Deep, et al.
Publicado: (2012)

Plurihormone secreting pituitary macroadenoma masquerading as thyrotoxicosis: Clinical presentation and diagnostic challenges
por: Maisnam, Indira, et al.
Publicado: (2012)

Cretinism revisited
por: Srivastav, Ankit, et al.
Publicado: (2012)

Gynaecomastia as the initial presentation of thyrotoxicosis
por: Sanyal, Triranjan, et al.
Publicado: (2012)

Familial glucocorticoid deficiency presenting with generalized hyperpigmentation in adolescence. Report of three siblings
por: Shivaprasad, K. S., et al.
Publicado: (2012)

Efficacy and Safety of Cabergoline as First Line Treatment for Invasive Giant Prolactinoma
por: Cho, Eun-Hee, et al.
Publicado: (2009)

SAT-474 Giant Prolactinoma Case Series Assessing Response on Initial Dose of Cabergoline
por: Madan Paramasivan, Ameena, et al.
Publicado: (2019)

Acromegaly presenting as hirsuitism: Uncommon sinister aetiology of a common clinical sign
por: Jain, Rajesh, et al.
Publicado: (2012)

Diabetes and Primary Infertility in Young Males: Do Not Forget Cystic Fibrosis
por: Chakraborty, Partha Pratim, et al.
Publicado: (2015)

Conservative management of severe bilateral emphysematous pyelonephritis: Case series and review of literature
por: Dutta, Deep, et al.
Publicado: (2013)

Serum vitamin-D predicts insulin resistance in individuals with prediabetes
por: Dutta, Deep, et al.
Publicado: (2013)

Authors’ response
por: Dutta, Deep, et al.
Publicado: (2014)

Authors’ response
por: Dutta, Deep, et al.
Publicado: (2014)

Decrease of Proliferative Potential and Vascular Density of Giant Prolactinoma in Patients Treated with Cabergoline
por: Astaf’eva, Ludmila, et al.
Publicado: (2020)

De Novo Psychiatric Disorders in a Woman With Giant Prolactinoma Treated With Cabergoline
por: Belhadj Slimane, Chayma, et al.
Publicado: (2023)

Pancreatic carcinoma in fibrocalcific pancreatic diabetes: An eastern India perspective
por: Chakraborty, Partha Pratim, et al.
Publicado: (2012)

Pituitary Apoplexy during Treatment of Prolactinoma with Cabergoline
por: Ghadirian, Hesam, et al.
Publicado: (2018)

Isolated Cushing’s Syndrome in Early Infancy Due to Left Adrenal Adenoma: An Unusual Aetiology
por: Dutta, Deep, et al.
Publicado: (2012)

Medical Management of Thyroid Ectopia: Report of Three Cases
por: Dutta, Deep, et al.
Publicado: (2013)

Foster Kennedy syndrome secondary to a giant prolactinoma with a remarkable response to cabergoline
por: Kanj, Usama, et al.
Publicado: (2022)

Hypophosphatemic rickets: A case of recurrent pathological fractures
por: Baidya, Arjun, et al.
Publicado: (2012)

Profile of vitamin D in a cohort of physicians and diabetologists in Kolkata
por: Baidya, Arjun, et al.
Publicado: (2012)

Primary Hyperparathyroidism Masquerading as Rickets: Diagnostic Challenge and Treatment Outcomes
por: Dutta, Deep, et al.
Publicado: (2013)

Needle aspirate PTH in diagnosis of primary hyperparathyroidism due to intrathyroidal parathyroid cyst
por: Dutta, Deep, et al.
Publicado: (2013)

Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline
por: Pala, Nazir A., et al.
Publicado: (2015)

Long-term cardiac (valvulopathy) safety of cabergoline in prolactinoma
por: Khare, Shruti, et al.
Publicado: (2017)

Neuropsychiatric Effects in Patients With Invasive Prolactinomas Treated With Cabergoline
por: Calva-González, Metztli, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bdo1lu22re1s6dt6dnvrh0kenf